Clinical Trials Logo
  1. Home
  2. Community-Acquired Pneumonia
  3. NCT03098914
  4. Details
NCT03098914 Clinical Trial

Clinical Characteristics and Microbiology of Community-Acquired Pneumonia

Community-acquired Pneumonia Clinical Trial

Official title:
Clinical Characteristics and Microbiology of Community-Acquired Pneumonia: A Prospective Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03098914
Other study ID # Beijing Haidian Hospital
Secondary ID
Status Recruiting
Phase N/A
First received March 22, 2017
Last updated April 3, 2017
Start date April 11, 2017
Est. completion date May 1, 2019

Study information
Verified date April 2017
Source Beijing Haidian Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Community-Acquired Pneumonia has become common. Additionally, the mortality is high. But the epidemiology of pathogen is various in different areas, which is crucial for the key treatment. In addition, the risk factors of patients who died in 3 or 7 days in china is not clear, comparing with patients who died in 14 or 28 days or who survived.

Recruitment information / eligibility
Status Recruiting
Enrollment 2000
Est. completion date May 1, 2019
Est. primary completion date April 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Confirmed community acquired pneumonia

- Age=18 ys

Exclusion Criteria:

- HIV infection

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Cohort Study; pathogen; clinical features
Cohort Study; pathogen; clinical features

Locations
Country Name City State
China Beijing Haidian Hospital Beijing Beijing

Sponsors (3)
Lead Sponsor Collaborator
Beijing Haidian Hospital Beijing Tsinghua Chang Gung Hospital, Chinese PLA General Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary the epidemiology of pathogen of community-acquired pneumonia in the three hospitals screen out the pathogen of community-acquired pneumonia confirmed as community-acquired pneumonia (2 weeks)
Secondary risk factors of patients who died in 3 or 7 days patients who die in 3 or 7 days in one week(3 days or 7days)
See also
  Status Clinical Trial Phase
Recruiting NCT05722938 - Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) Phase 3
Terminated NCT04972318 - Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia N/A
Recruiting NCT06065618 - Characteristics of Hospitalized Patients With Community-acquired Pneumonia
Not yet recruiting NCT03675178 - Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumonia Phase 4
Not yet recruiting NCT04166110 - Antibiotic Therapy In Respiratory Tract Infections N/A
Completed NCT02380352 - Short-course Antimicrobial Therapy for Paediatric Respiratory Infections Phase 4
Completed NCT01671280 - Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) N/A
Completed NCT02555852 - Proton Pump Inhibitors and Risk of Community-acquired Pneumonia N/A
Recruiting NCT00752947 - Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors Phase 4
Completed NCT00140023 - Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia Phase 3
Recruiting NCT04089787 - Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia Phase 4
Completed NCT05356494 - Postural Drainage and PEP Technique in Community Acquired Pneumonia N/A
Completed NCT05133752 - Oral Nemonoxacin in Treating Elderly Patients With CAP Phase 4
Not yet recruiting NCT06291012 - Stopping Pneumonia Antibiotherapy Regimen Early Phase 4
Recruiting NCT05002192 - A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia
Completed NCT03452826 - Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia N/A
Terminated NCT04071041 - Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia. Phase 3
Completed NCT03474991 - KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP Phase 3
Withdrawn NCT01662258 - Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP N/A
Completed NCT01683487 - Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. Phase 4